These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30513136)

  • 1. Analysis of sialic acid levels in Chinese intravenous immunoglobulins by high-performance liquid chromatography with fluorescence detection.
    Ma L; Zhang W; Hou M; Li D; Liu F; Du X; Jiang P; Wang Z; Zhang R; Cao H; Ye S; Li C
    Biomed Chromatogr; 2019 Apr; 33(4):e4452. PubMed ID: 30513136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation.
    Käsermann F; Boerema DJ; Rüegsegger M; Hofmann A; Wymann S; Zuercher AW; Miescher S
    PLoS One; 2012; 7(6):e37243. PubMed ID: 22675478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.
    Leontyev D; Katsman Y; Ma XZ; Miescher S; Käsermann F; Branch DR
    Transfusion; 2012 Aug; 52(8):1799-805. PubMed ID: 22257295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
    Fokkink WJ; Selman MH; Dortland JR; Durmuş B; Kuitwaard K; Huizinga R; van Rijs W; Tio-Gillen AP; van Doorn PA; Deelder AM; Wuhrer M; Jacobs BC
    J Proteome Res; 2014 Mar; 13(3):1722-30. PubMed ID: 24533874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A close look at human IgG sialylation and subclass distribution after lectin fractionation.
    Stadlmann J; Weber A; Pabst M; Anderle H; Kunert R; Ehrlich HJ; Peter Schwarz H; Altmann F
    Proteomics; 2009 Sep; 9(17):4143-53. PubMed ID: 19688751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc.
    Anumula KR
    J Immunol Methods; 2012 Aug; 382(1-2):167-76. PubMed ID: 22683540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells.
    Issekutz AC; Rowter D; Miescher S; Käsermann F
    Clin Immunol; 2015 Oct; 160(2):123-32. PubMed ID: 25982320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.
    Nagelkerke SQ; Dekkers G; Kustiawan I; van de Bovenkamp FS; Geissler J; Plomp R; Wuhrer M; Vidarsson G; Rispens T; van den Berg TK; Kuijpers TW
    Blood; 2014 Dec; 124(25):3709-18. PubMed ID: 25352126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils.
    Campbell IK; Miescher S; Branch DR; Mott PJ; Lazarus AH; Han D; Maraskovsky E; Zuercher AW; Neschadim A; Leontyev D; McKenzie BS; Käsermann F
    J Immunol; 2014 Jun; 192(11):5031-8. PubMed ID: 24760152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-aβ oligomer IgG and surface sialic acid in intravenous immunoglobulin: measurement and correlation with clinical outcomes in Alzheimer's disease treatment.
    Kwon H; Crisostomo AC; Smalls HM; Finke JM
    PLoS One; 2015; 10(3):e0120420. PubMed ID: 25826319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity.
    Washburn N; Schwab I; Ortiz D; Bhatnagar N; Lansing JC; Medeiros A; Tyler S; Mekala D; Cochran E; Sarvaiya H; Garofalo K; Meccariello R; Meador JW; Rutitzky L; Schultes BC; Ling L; Avery W; Nimmerjahn F; Manning AM; Kaundinya GV; Bosques CJ
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1297-306. PubMed ID: 25733881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.
    Anthony RM; Nimmerjahn F; Ashline DJ; Reinhold VN; Paulson JC; Ravetch JV
    Science; 2008 Apr; 320(5874):373-6. PubMed ID: 18420934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced sialylation of a human chimeric IgG1 variant produced in human and rodent cell lines.
    Mimura Y; Kelly RM; Unwin L; Albrecht S; Jefferis R; Goodall M; Mizukami Y; Mimura-Kimura Y; Matsumoto T; Ueoka H; Rudd PM
    J Immunol Methods; 2016 Jan; 428():30-6. PubMed ID: 26627984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
    Quast I; Keller CW; Maurer MA; Giddens JP; Tackenberg B; Wang LX; Münz C; Nimmerjahn F; Dalakas MC; Lünemann JD
    J Clin Invest; 2015 Nov; 125(11):4160-70. PubMed ID: 26436649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia.
    Guhr T; Bloem J; Derksen NI; Wuhrer M; Koenderman AH; Aalberse RC; Rispens T
    PLoS One; 2011; 6(6):e21246. PubMed ID: 21731683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traces of pFc' in IVIG interact with human IgG Fc domains and counteract aggregation.
    Rispens T; Himly M; Ooievaar-De Heer P; den Bleker TH; Aalberse RC
    Eur J Pharm Sci; 2010 Apr; 40(1):62-8. PubMed ID: 20211252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal B Cell Extrinsic IgG Glycan Modifications of Pro- and Anti-Inflammatory IgG Preparations
    Schaffert A; Hanić M; Novokmet M; Zaytseva O; Krištić J; Lux A; Nitschke L; Peipp M; Pezer M; Hennig R; Rapp E; Lauc G; Nimmerjahn F
    Front Immunol; 2019; 10():3024. PubMed ID: 31998308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-MS analysis of polyclonal IgGs using IdeS enzymatic proteolysis for oxidation monitoring.
    Leblanc Y; Romanin M; Bihoreau N; Chevreux G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 961():1-4. PubMed ID: 24837162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc glycan-modulated immunoglobulin G effector functions.
    Quast I; Lünemann JD
    J Clin Immunol; 2014 Jul; 34 Suppl 1():S51-5. PubMed ID: 24760108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin.
    Othy S; Topçu S; Saha C; Kothapalli P; Lacroix-Desmazes S; Käsermann F; Miescher S; Bayry J; Kaveri SV
    Eur J Immunol; 2014 Jul; 44(7):2059-63. PubMed ID: 24700174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.